Neuro


























You would have found out by now if you interviewed this week. If you fit the “Lilly” profile the. You are in. If you have experience you are out. They have a profile.

This is bad practice if this is the case. Why not post what they really want on the job ad and not a bunch of ish they don't really care about. Companies and interviewers needs to get called out on if this is the case!!
 








Amgen priced this low,

Insurers are jumping on it. Plus, first to market up. Lilly will get sloppy seconds. All their launches are bad.

I'm here to tell you there is hope for us. Higher ups actively recruiting two Amgen cgrp guys who have built this market and might leave Amgen for the right price. They will singlehandedly get customers to switch products with one phone call. We hope to recruit Nelson and Ross, we will be the market leader day 1.
 








I'm here to tell you there is hope for us. Higher ups actively recruiting two Amgen cgrp guys who have built this market and might leave Amgen for the right price. They will singlehandedly get customers to switch products with one phone call. We hope to recruit Nelson and Ross, we will be the market leader day 1.

Nelson Costa is a joke, he’s terrible.
He was with Avanir for their migraine
launch before he went to Amgen and
the launch was a disaster. No KOL’s
did anything for Nelson.
 
















































































Nelson Costa is a joke, he’s terrible.
He was with Avanir for their migraine
launch before he went to Amgen and
the launch was a disaster. No KOL’s
did anything for Nelson.

Word is Neuro spec is adding a sales Director and we are considering an Amg guy, not Nelson. I have heard the other guys name floating around home office.

Amg will get pounced by all the new entrants. Good luck all with the offers.
 
































Word is Neuro spec is adding a sales Director and we are considering an Amg guy, not Nelson. I have heard the other guys name floating around home office.

Amg will get pounced by all the new entrants. Good luck all with the offers.

Amgen will not get pounced. Amgen has solidified their place. We're going to have the same problems here they had. There's enough demand out there. Lilly luanches terribly and the drug has more cv problems working on the ligand and not just blocking the specific cgrp receptor. We are going to get killed. and pcp aren't going to write. it's going to be hard